Unser Mitarbeiter, Axel Haack, hatte die großartige Gelegenheit, die Pharmalabore der GBA Group vorzustellen und er begann mit Pharmacelsus (Teil 1/5).

In einer feierlichen Eröffnungszeremonie vor Kunden, Kollegen und vielen Gästen wurde das neue Gebäude in Neuried eröffnet.

Die GBA Pharma Labs arbeiten nun am neuen Standort mit über 2.400 Quadratmetern Laborfläche und eigenen Arbeitsräumen für die Chromatography, physischen Chemie und Arzneimittelauflösungstests.

Mit über 30 HPLC-Geräten, 3 Geräten zur Aminosäureanalytik, 10 GC-Systemen und 14 Geräten zur Prüfung der Arzneimittelauflösung ist das neue Gebäude hochmodern ausgestattet.

Zu diesem besonderen Anlass ist ein Video entstanden, das wir gerne mit Ihnen teilen möchten.

Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.

The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.

Take a look at ABF´s brand-new PBMC Film. As we all know, analysis of immune cells are getting more and more into the focus during the clinical development program of new therapeutics. However, everything starts with the timely isolation by trained operators and the subsequent storage. ABF has implemented such network, connecting clinical sites with qualified isolation labs.

ABF Pharmaceutical Services GmbH (part of GBA Group Pharma) is a Viennese company founded in 2004, specializing in all aspects of international clinical trials, including project management, manufacturing, logistics and EU approval of investigational medicinal products, as well as import, storage and logistics for approved pharmaceuticals. ABF has a total area of 2,750 square metres (production and warehouse 1,580 m2 and office 1,170m2). State-of-theart processing facilities offer 1,089 pallet spaces (948 spaces at room temperature/ 141 for cold storage), 5 packaging rooms (primary packaging/ secondary packaging/ cold chain) and a GMP warehouse for investigational medicinal products and commercial goods. In 2016, ABF became a member of GBA Group Pharma, one of Europe's largest and most experienced service groups in the pharmaceutical and biotech sector. With its preclinical services, analytical test laboratories and international central laboratory, the company generates annual sales of around 50 million euros.